Iron Profile in Patients With Congenital Cyanotic Heart Disease
NCT04104061 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30
Last updated 2019-09-26
Summary
Iron is a vital substrate for hemoglobin production and sufficient iron stores are necessary to achieve and maintain adequate levels of hemoglobin.
Conditions
- Congenital; Cyanotic Heart Disease
Interventions
- OTHER
-
iron profile
blood test
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2020-10-01
- Completion
- 2021-10-01
More Related Trials
-
Effect of IV Iron in Patients With Heart Failure With Preserved Ejection Fraction
NCT03074591 ·Status: COMPLETED ·Phase: PHASE4
-
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality
NCT03036462 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease
NCT00459225 ·Status: WITHDRAWN ·Phase: NA
-
Red Cell Distribution Width Index Versus Red Cell Distribution Width as Discriminating Guide for Iron Deficiency Anaemia and Beta Thalassemia Trait .
NCT03868306 ·Status: UNKNOWN
-
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
NCT01925703 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Deficiency in Pediatric Heart Surgery
NCT06276608 ·Status: RECRUITING
-
IRON DEFICIENCY ANEMIA IN RELATION TO PINCH STRENGTH AND HAND DEXTERITY IN PRESCHOOL CHILDREN
NCT05959122 ·Status: COMPLETED
-
Hospitalization & Mortality in Patients With Iron Deficiency CKD and HF Treated With i.v. Iron.
NCT02392910 ·Status: COMPLETED ·Phase: PHASE4
-
Methemoglobinemia Following Intravenous Iron Treatment
NCT06309641 ·Status: COMPLETED
-
Intravenous Iron in paTients With Heart failURe and Reduced Ejection fracTion (HFREF) pLus Iron dEficiency
NCT03079518 ·Status: COMPLETED ·Phase: PHASE2
-
Hepcidin as a Predictor for the IVI Mediated Increase in Haemoglobin Levels
NCT04263571 ·Status: UNKNOWN
-
Intravenous Iron Sucrose for Acute Decompensated Heart Failure Patients With Reduced Ejection Fraction and Iron Deficiency
NCT06703411 ·Status: COMPLETED ·Phase: PHASE4
-
Iron Deficiency and FGF23 Regulation in CKD and HF
NCT03106298 ·Status: COMPLETED
-
Intravenous Iron Supplement for Iron Deficiency in Patients With Severe Aortic Stenosis
NCT04206228 ·Status: COMPLETED ·Phase: PHASE2
-
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 ·Status: UNKNOWN
-
Hemochromatosis--Genetic Prevalence and Penetrance
NCT00006312 ·Status: COMPLETED
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
Oral Iron Supplementation in Pulmonary Hypertension
NCT01446848 ·Status: COMPLETED ·Phase: NA
-
Intravenous Iron in Patients With Severe Chronic Heart Failure and Chronic Kidney Disease
NCT00384657 ·Status: WITHDRAWN ·Phase: PHASE3
-
Maternal Iron Deficiency and/or Iron Deficiency Anemia to Neonatal Hemoglobin Concentration and Iron Stores
NCT06871917 ·Status: NOT_YET_RECRUITING
-
Relationship Between Blood Groups , Iron Deficiency Anemia and Helicobacter Pylori in Children.
NCT05841433 ·Status: NOT_YET_RECRUITING
-
ORal IrON Supplementation with Ferric Maltol in Treating Iron Deficiency and Anaemia in Patients with Heart Failure (ORION-HF)
NCT05697211 ·Status: COMPLETED ·Phase: PHASE4
-
Frequency and Impact of Iron Deficiency in Pain Clinic Patients
NCT06665516 ·Status: COMPLETED
-
IV Iron Versus Standard Treatment for Iron Deficiency Anemia in the Emergency Department
NCT05153278 ·Status: COMPLETED
-
Cardiac Function in Patients With Hereditary Hemochromatosis
NCT00068159 ·Status: COMPLETED